NCT03272971View on ClinicalTrials.gov

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

January 30, 2019

Study Completion Date

January 30, 2019

Conditions
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell
Interventions
DEVICE

Radio-frequency Ablation

The intervention consists of a bronchoscopic approach to ablate lung tumors with radiofrequency.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

Sponsors
All Listed Sponsors
collaborator

Uptake Medical Technology, Inc.

INDUSTRY

lead

Broncus Medical Inc

INDUSTRY